Bogomolova L G, Suslov V S, Zarivchatsky M F
Vestn Khir Im I I Grek. 1976 Jun;116(6):526.
The substance gelvisol obtained in Leningrad Research Institute of Hematology and Blood Transfusion was employed in 198 patients with abdominal organs pathology. There was noted a positive effect of the peroral plasma substitutor on the circulatory blood volume and its components, electrolytic balance, general condition of the operated patients. The authors have elaborated the method of gelvisol administration both per os (30-50 ml each 1-2 hours; up to 1000-2000 ml a day) and in intraintestinal administration via a sound.
列宁格勒血液学与输血研究所获得的代血浆制剂“盖维索”用于198例腹部器官病变患者。经口血浆代用品对循环血量及其成分、电解质平衡以及手术患者的一般状况有积极作用。作者已详细阐述了“盖维索”的给药方法,即口服(每1 - 2小时30 - 50毫升;每天最多1000 - 2000毫升)以及通过探子进行肠内给药。